Martingale Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$401K	Hold	44,802	–	–	0.01%	689
2025 Q4	$270K	Sell	44,802 -2,212	-5%	-$13.2K	0.01%	708
2025 Q3	$268K	Hold	47,014	–	–	0.01%	710
2025 Q2	$237K	Hold	47,014	–	–	0.01%	738
2025 Q1	$305K	Hold	47,014	–	–	0.01%	678
2024 Q4	$345K	Sell	47,014 -12	-0%	-$95	0.01%	666
2024 Q3	$352K	Buy	47,026 +104	+0.2%	+$903	0.01%	687
2024 Q2	$418K	Buy	46,922 +898	+2%	+$8.61K	0.01%	638
2024 Q1	$466K	Sell	46,024 -19	-0%	-$194	0.01%	631
2023 Q4	$463K	Buy	46,043 +9,834	+27%	+$89.9K	0.01%	630
2023 Q3	$339K	Buy	36,209 +10,122	+39%	+$144K	0.01%	669
2023 Q2	$640K	Buy	26,087 +912	+4%	+$22.9K	0.01%	560
2023 Q1	$586K	Buy	25,175 +8,208	+48%	+$210K	0.01%	581
2022 Q4	$429K	Buy	16,967 +6,401	+61%	+$157K	0.01%	650
2022 Q3	$204K	Buy	+10,566	New	+$269K	﹤0.01%	780
2021 Q1	–	Sell	-9,523	Closed	-$256K	–	924
2020 Q4	$256K	Buy	+9,523	New	+$310K	﹤0.01%	780